🇺🇸 FDA
Pipeline program

Qvar® (beclometasone dipropionate HFA)

2012RC16

Approved small_molecule completed

Quick answer

Qvar® (beclometasone dipropionate HFA) for Asthma is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials